Clinical Trial Update: Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing GNbAC1 in patients with Type 1 diabetes within 4 years of onset has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GNbAC1

Snippet

Sponsor: GeNeuro Australia PTY Ltd | Conditions: Diabetes Mellitus Type 1 | Phase 2 | Status: COMPLETED